Search Results

There are 6093 results for: content related to: Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01)

  1. Cost-utility and budget impact analyses of gefitinib in second-line treatment for advanced non-small cell lung cancer from Thai payer perspective

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 53–61, Sumitra THONGPRASERT, Sirana TINMANEE and Unchalee PERMSUWAN

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1743-7563.2012.01528.x

  2. You have full text access to this OnlineOpen article
    Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3

    Cancer Science

    Volume 106, Issue 9, September 2015, Pages: 1202–1211, Terufumi Kato, Hiroshige Yoshioka, Isamu Okamoto, Akira Yokoyama, Toyoaki Hida, Takashi Seto, Katsuyuki Kiura, Dan Massey, Yoko Seki and Nobuyuki Yamamoto

    Version of Record online : 25 JUL 2015, DOI: 10.1111/cas.12723

  3. You have free access to this content
    Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung

    Cancer

    Volume 118, Issue 4, 15 February 2012, Pages: 1032–1039, Gilberto de Lima Lopes Jr., Joel E. Segel, Daniel S. W. Tan, Young K. Do, Tony Mok and Eric A. Finkelstein

    Version of Record online : 26 JUL 2011, DOI: 10.1002/cncr.26372

  4. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer

    Intervention Review

    The Cochrane Library

    Janette Greenhalgh, Kerry Dwan, Angela Boland, Victoria Bates, Fabio Vecchio, Yenal Dundar, Pooja Jain and John A Green

    Published Online : 25 MAY 2016, DOI: 10.1002/14651858.CD010383.pub2

  5. You have free access to this content
    Poster Presentation – Lung Cancer

    Respirology

    Volume 19, Issue S3, November 2014, Pages: 154–172,

    Version of Record online : 30 OCT 2014, DOI: 10.1111/resp.12417_10

  6. You have full text access to this OnlineOpen article
    Medical management of lung cancer: Experience in China

    Thoracic Cancer

    Volume 6, Issue 1, January 2015, Pages: 10–16, Yuankai Shi and Yan Sun

    Version of Record online : 7 JAN 2015, DOI: 10.1111/1759-7714.12168

  7. Personalized medicine for lung cancer: new challenges for pathology

    Histopathology

    Volume 60, Issue 4, March 2012, Pages: 531–546, Keith M Kerr

    Version of Record online : 14 SEP 2011, DOI: 10.1111/j.1365-2559.2011.03854.x

  8. You have free access to this content
    Targeted therapy: An evolving world of lung cancer

    Respirology

    Volume 16, Issue 1, January 2011, Pages: 13–21, Kwok-Chi LAM and Tony S. MOK

    Version of Record online : 16 AUG 2010, DOI: 10.1111/j.1440-1843.2010.01821.x

  9. You have free access to this content
    Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma

    British Journal of Pharmacology

    Volume 166, Issue 2, May 2012, Pages: 532–553, Roberto E Favoni, Antonio Daga, Paolo Malatesta and Tullio Florio

    Version of Record online : 13 APR 2012, DOI: 10.1111/j.1476-5381.2012.01873.x

  10. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A250–A480,

    Version of Record online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_2.x

  11. You have full text access to this OnlineOpen article
    Survival of patients with advanced lung adenocarcinoma before and after approved use of gefitinib in China

    Thoracic Cancer

    Volume 6, Issue 5, September 2015, Pages: 636–642, Yu-Tao Liu, Xue-Zhi Hao, Jun-Ling Li, Xing-Sheng Hu, Yan Wang, Zi-Ping Wang, Hong-Yu Wang, Bin Wang, Xiao-Hong Han, Xiang-Ru Zhang and Yuan-Kai Shi

    Version of Record online : 21 MAY 2015, DOI: 10.1111/1759-7714.12267

  12. You have free access to this content
    Poster Presentation – Interstitial Lung Disease

    Respirology

    Volume 19, Issue S3, November 2014, Pages: 145–153,

    Version of Record online : 30 OCT 2014, DOI: 10.1111/resp.12417_9

  13. You have free access to this content
    RESEARCH PODIUM ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A239–A250,

    Version of Record online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_1.x

  14. You have free access to this content
    Maintenance therapy in nonsmall-cell lung cancer

    Cancer

    Volume 115, Issue 22, 15 November 2009, Pages: 5143–5154, Tony S. K. Mok and Suresh S. Ramalingam

    Version of Record online : 5 AUG 2009, DOI: 10.1002/cncr.24563

  15. You have full text access to this Open Access content
    Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports

    Cancer Science

    Volume 102, Issue 5, May 2011, Pages: 1032–1037, Takehito Shukuya, Toshiaki Takahashi, Rieko Kaira, Akira Ono, Yukiko Nakamura, Asuka Tsuya, Hirotsugu Kenmotsu, Tateaki Naito, Kyoichi Kaira, Haruyasu Murakami, Masahiro Endo, Kazuhisa Takahashi and Nobuyuki Yamamoto

    Version of Record online : 28 FEB 2011, DOI: 10.1111/j.1349-7006.2011.01887.x

  16. EGFR Tyrosine Kinase Inhibitors and Monoclonal Antibodies: Clinical Trial Review

    Lung Cancer, Fourth Edition

    Kathryn F. Mileham, Edward S. Kim, William N. William, Pages: 406–420, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118468791.ch26

  17. You have free access to this content
    A randomized phase 2 trial of erlotinib versus pemetrexed as second-line therapy in the treatment of patients with advanced EGFR wild-type and EGFR FISH-positive lung adenocarcinoma

    Cancer

    Volume 120, Issue 9, 1 May 2014, Pages: 1379–1386, Ning Li, Wei Ou, Hua Yang, Qian-Wen Liu, Song-Liang Zhang, Bao-Xiao Wang and Si-Yu Wang

    Version of Record online : 30 JAN 2014, DOI: 10.1002/cncr.28591

  18. Histology as a treatment effect modifier in advanced non-small cell lung cancer: A systematic review of the evidence

    Respirology

    Volume 16, Issue 8, November 2011, Pages: 1210–1220, LACHLAN STANDFIELD, ADÈLE R. WESTON, HELEN BARRACLOUGH, MAXIMILIANO VAN KOOTEN and NICK PAVLAKIS

    Version of Record online : 27 OCT 2011, DOI: 10.1111/j.1440-1843.2011.02025.x

  19. You have full text access to this Open Access content
    Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan

    Thoracic Cancer

    Volume 5, Issue 4, July 2014, Pages: 289–296, Kazuhiro Asami, Masaaki Kawahara, Tomonori Hirashima, Hidekazu Suzuki, Kyoichi Okishio, Naoki Omachi, Motohiro Tamiya, Akihiro Tamiya, Aya Hirooka, Keiko Nakao, Taisuke Tsuji and Shinji Atagi

    Version of Record online : 3 JUL 2014, DOI: 10.1111/1759-7714.12091

  20. Non-Small-Cell Lung Cancer

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt012